Last reviewed · How we verify
PLENVU powder for oral solution
At a glance
| Generic name | PLENVU powder for oral solution |
|---|---|
| Also known as | NER1006 |
| Sponsor | Norgine |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study Assessing CLENPIQ as Bowel Preparation for Pediatric Colonoscopy (PHASE1, PHASE2)
- Combination of Lactulose and Polyethylene Glycol Electrolytes Powder (PEG-ELS) for Bowel Preparation in Type II Diabetes Mellitus Patients (NA)
- What Laxative Should be Used After Hip Fracture Surgery? (PHASE4)
- Clinical Study of Bowel Preparation Before Colonoscopy (NA)
- A Pharmacokinetic Study of PLENVU® in Healthy Subjects (PHASE1)
- To Assess Safety, Tolerability and Pharmacokinetics of BI 730357 in Healthy Male Volunteers (PHASE1)
- Study Comparing the Bowel Cleansing Efficacy of PLENVU® Versus SELG-ESSE® Using a 2-Day Split Dosing Regimen. (PHASE4)
- Polyethylene Glycol and Intestinal Inflammation in Cystic Fibrosis (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PLENVU powder for oral solution CI brief — competitive landscape report
- PLENVU powder for oral solution updates RSS · CI watch RSS
- Norgine portfolio CI